Inozyme Pharma, Inc. (INZY)
Jul 1, 2025 - INZY was delisted (reason: acquired by BMRN)
4.000
0.00 (0.00%)
Inactive · Last trade price on Jun 30, 2025
Inozyme Pharma Market Cap
Inozyme Pharma is not actively traded anymore. When Inozyme Pharma last traded, it had a market cap or net worth of $259.66 million.
Market Cap
259.66M
Enterprise Value
221.84M
1-Year Change
-16.04%
Ranking
n/a
Category
Stock Price
$4.00
Market Cap Chart
Since July 24, 2020, Inozyme Pharma's market cap has decreased from $356.32M to $259.66M, a decrease of -27.13%. That is a compound annual growth rate of -6.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 259.66M | 45.92% |
| Dec 31, 2024 | 177.95M | -32.37% |
| Dec 29, 2023 | 263.10M | 520.31% |
| Dec 30, 2022 | 42.41M | -73.72% |
| Dec 31, 2021 | 161.39M | -66.54% |
| Dec 31, 2020 | 482.42M | 35.39% |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition